ATE133078T1 - Einrichtung zur transdermalen wirkstoffabgabe - Google Patents

Einrichtung zur transdermalen wirkstoffabgabe

Info

Publication number
ATE133078T1
ATE133078T1 AT92630083T AT92630083T ATE133078T1 AT E133078 T1 ATE133078 T1 AT E133078T1 AT 92630083 T AT92630083 T AT 92630083T AT 92630083 T AT92630083 T AT 92630083T AT E133078 T1 ATE133078 T1 AT E133078T1
Authority
AT
Austria
Prior art keywords
active ingredients
transdermal delivery
liquid
gel
delivered
Prior art date
Application number
AT92630083T
Other languages
English (en)
Inventor
Joseph Gross
Shlomo Zucker
Original Assignee
Scient Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scient Innovations Ltd filed Critical Scient Innovations Ltd
Application granted granted Critical
Publication of ATE133078T1 publication Critical patent/ATE133078T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92630083T 1991-09-12 1992-09-10 Einrichtung zur transdermalen wirkstoffabgabe ATE133078T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/759,006 US5356632A (en) 1991-09-12 1991-09-12 Transdermal drug delivery device

Publications (1)

Publication Number Publication Date
ATE133078T1 true ATE133078T1 (de) 1996-02-15

Family

ID=25054021

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92630083T ATE133078T1 (de) 1991-09-12 1992-09-10 Einrichtung zur transdermalen wirkstoffabgabe

Country Status (8)

Country Link
US (1) US5356632A (de)
EP (1) EP0532451B1 (de)
JP (1) JPH05212124A (de)
AT (1) ATE133078T1 (de)
DE (1) DE69207688T2 (de)
DK (1) DK0532451T3 (de)
ES (1) ES2082423T3 (de)
GR (1) GR3019575T3 (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE155045T1 (de) * 1991-11-13 1997-07-15 Elan Corp Plc Vorrichtung zur verabreichung von heilmitteln
US6009345A (en) * 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
EP0818995A1 (de) * 1995-04-07 1998-01-21 Novartis AG Transdermales system mit elektroden als initialisierungssystem
WO2000023144A1 (en) 1995-04-23 2000-04-27 Electromagnetic Bracing Systems, Inc. Transdermal active drug delivery system and method
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US5954685A (en) * 1996-05-24 1999-09-21 Cygnus, Inc. Electrochemical sensor with dual purpose electrode
US6246904B1 (en) 1996-12-17 2001-06-12 Alza Corporation Electrotransport drug delivery reservoirs containing inert fillers
US6650934B2 (en) 1996-12-17 2003-11-18 Alza Corp Polymeric foam reservoirs for an electrotransport delivery device
US6157858A (en) * 1996-12-26 2000-12-05 Elan Pharma International Limited Device for the delivery of a substance to a subject and improved electrode assembly
US6078842A (en) * 1997-04-08 2000-06-20 Elan Corporation, Plc Electrode and iontophoretic device and method
TW368420B (en) * 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
EP1028777B1 (de) * 1997-11-04 2002-07-24 Genetronics, Inc. Kombinierte elektroporation-und iontophoresevorrichtung zur medikament-und genverabreichung
US6775569B2 (en) * 1997-11-05 2004-08-10 Hisamitsu Pharmaceutical Co., Inc. Electroporation device for in vivo delivery of therapeutic agents
ES2232111T3 (es) 1998-01-28 2005-05-16 Alza Corporation Conjunto de electrodo de electrotransporte que presenta una menor resistencia inicial.
DE19816143A1 (de) * 1998-04-09 1999-10-21 Fischer Wilfried Transdermales Applikationssystem (TDS) mit Elektrodenraster
US6757560B1 (en) 1999-04-09 2004-06-29 Novosis Pharma Ag Transdermal delivery system (TDS) with electrode network
EP1115454B1 (de) * 1998-08-31 2006-10-25 Travanti Pharma Inc Gesteuerte medikamentdosierungsvorrichtung
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6713291B2 (en) * 1999-01-28 2004-03-30 Alan D. King Electrodes coated with treating agent and uses thereof
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6421561B1 (en) 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
US6653014B2 (en) 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
FR2830766B1 (fr) * 2001-10-12 2004-03-12 Optis France Sa Dispositif de delivrance de medicaments par iontophorese transpalpebrale
US6916120B2 (en) * 2002-01-30 2005-07-12 Adc Telecommunications, Inc. Fiber optic connector and method
FR2835755A1 (fr) * 2002-02-13 2003-08-15 Metalarc Biomedical Dispositif d'electrolipolyse pour le traitement de la cellulite
EP1457233B1 (de) 2003-03-12 2007-07-11 Novosis AG Transdermales Wirkstoffverabreichungssystem mit Elektrodenraster
US7476222B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
US7486989B2 (en) * 2003-06-30 2009-02-03 Johnson & Johnson Consumer Companies, Inc. Device for delivery of oxidizing agents to barrier membranes
CN104147694A (zh) * 2003-06-30 2014-11-19 强生消费者公司 处理人或动物屏障膜的装置
US7480530B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US7507228B2 (en) 2003-06-30 2009-03-24 Johnson & Johnson Consumer Companies, Inc. Device containing a light emitting diode for treatment of barrier membranes
US7477941B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of exfoliating the skin with electricity
US7477940B2 (en) * 2003-06-30 2009-01-13 J&J Consumer Companies, Inc. Methods of administering an active agent to a human barrier membrane with galvanic generated electricity
US7477939B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of treating a wound with galvanic generated electricity
US7477938B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Cosumer Companies, Inc. Device for delivery of active agents to barrier membranes
US7479133B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Methods of treating acne and rosacea with galvanic generated electricity
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050038473A1 (en) * 2003-07-14 2005-02-17 Dov Tamarkin Device and method for the treatment of pilosebaceous disorders
US20050226921A1 (en) * 2004-04-13 2005-10-13 Kortzebom Robert N Non-invasive analysis and controlled dosage transdermal active patch
FR2869120B1 (fr) * 2004-04-15 2006-08-25 World Wide Watch Montre interactive.
US20060088581A1 (en) * 2004-09-22 2006-04-27 Thomas Blaszczykiewicz Device for delivery of therapeutic agent
BRPI0610603A2 (pt) * 2005-04-22 2010-07-06 Ecpoint Medical Inc aparelho para fornecer tratamento eletrolìtico ao tecido, método para o tratamento de uma porção in vivo de tecido, método para melhorar cosmeticamente uma área de pele não estética usando um tratamento eletrolìtico e método de depilação
US8840586B2 (en) 2006-08-23 2014-09-23 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7905868B2 (en) 2006-08-23 2011-03-15 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US8137314B2 (en) * 2006-08-23 2012-03-20 Medtronic Minimed, Inc. Infusion medium delivery device and method with compressible or curved reservoir or conduit
US8277415B2 (en) 2006-08-23 2012-10-02 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US20080097291A1 (en) 2006-08-23 2008-04-24 Hanson Ian B Infusion pumps and methods and delivery devices and methods with same
US7569050B2 (en) 2005-05-06 2009-08-04 Medtronic Minimed, Inc. Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portion
US8512288B2 (en) 2006-08-23 2013-08-20 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US8287923B2 (en) * 2005-06-10 2012-10-16 Medical College Of Georgia Research Institute, Inc. Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
MX2008010341A (es) 2006-02-09 2008-11-18 Deka Products Lp Sistemas y metodos adhesivos y perifericos para dispositivos medicos.
US7828764B2 (en) 2006-08-23 2010-11-09 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7794434B2 (en) 2006-08-23 2010-09-14 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7811262B2 (en) 2006-08-23 2010-10-12 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7682338B2 (en) 2006-08-23 2010-03-23 Medtronic Minimed, Inc. Infusion medium delivery system, device and method with needle inserter and needle inserter device and method
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
US8597243B2 (en) 2007-04-30 2013-12-03 Medtronic Minimed, Inc. Systems and methods allowing for reservoir air bubble management
US8323250B2 (en) 2007-04-30 2012-12-04 Medtronic Minimed, Inc. Adhesive patch systems and methods
US7959715B2 (en) 2007-04-30 2011-06-14 Medtronic Minimed, Inc. Systems and methods allowing for reservoir air bubble management
US7963954B2 (en) 2007-04-30 2011-06-21 Medtronic Minimed, Inc. Automated filling systems and methods
US8434528B2 (en) 2007-04-30 2013-05-07 Medtronic Minimed, Inc. Systems and methods for reservoir filling
EP2146760B1 (de) 2007-04-30 2018-10-10 Medtronic MiniMed, Inc. Reservoir-füllung, blasenkontrolle und infusionsmedium-abgabesysteme und verfahren dafür
US8613725B2 (en) 2007-04-30 2013-12-24 Medtronic Minimed, Inc. Reservoir systems and methods
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
WO2008157485A1 (en) * 2007-06-15 2008-12-24 Transport Pharmaceuticals, Inc. Current concentration system and method for electrokinetic delivery of medicaments
EP2162182A1 (de) * 2007-06-15 2010-03-17 Transport Pharmaceuticals, Inc. Verfahren und system zur verringerung der stromkonzentration bei der elektrokinetischen arzneiabgabe
WO2009000262A1 (de) * 2007-06-25 2008-12-31 Acino Ag Elektrophoretisches transdermales applikationssystem
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8150525B2 (en) 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
CA2737461A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
WO2010036682A2 (en) * 2008-09-24 2010-04-01 3M Innovative Properties Company Hydrogels with release element
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
EP2724739B1 (de) 2009-07-30 2015-07-01 Tandem Diabetes Care, Inc. Tragbares Infusionspumpensystem
US20130017188A1 (en) 2009-07-31 2013-01-17 The Brigham And Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
CN102711905B (zh) * 2009-11-13 2015-06-17 强生消费者公司 流电皮肤治疗装置
CA2794565C (en) 2010-04-08 2018-08-21 Emory University Substituted androst-4-ene diones
DE102010024558B4 (de) 2010-06-22 2016-04-21 Amw Gmbh Transdermales therapeutisches System mit Elektroden
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
WO2012151474A2 (en) 2011-05-04 2012-11-08 Trustees Of Boston University Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
WO2013003697A1 (en) 2011-06-30 2013-01-03 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
EP2543370A1 (de) 2011-07-06 2013-01-09 Georgia Health Sciences University Research Institute, Inc. Zusammensetzungen und Verfahren zur Behandlung des Herpes-simplex-Virus
US9243037B2 (en) 2011-11-10 2016-01-26 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
EP3036226B1 (de) 2013-08-22 2020-01-08 The General Hospital Corporation Hemmer der humanen 12/15-lipoxygenase
US11382883B2 (en) 2013-08-29 2022-07-12 Trustees Of Boston University Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
CN103499519A (zh) * 2013-10-10 2014-01-08 河南科技大学 一种复合物理场经皮给药实验装置
FR3015300B1 (fr) * 2013-12-20 2018-03-02 L'oreal Dispositif d'iontophorese a reservoir
CN107073259B (zh) * 2014-09-08 2021-03-02 法斯特麦德意大利有限公司 能够产生微电流的贴片
ES2921990T3 (es) 2014-09-10 2022-09-05 Bard Inc C R Apósito protector para un dispositivo médico colocado en la piel
EP3303286B1 (de) 2015-06-01 2023-10-04 Cedars-Sinai Medical Center An rela von nf-kb anbindende verbindungen zur verwendung bei der behandlung von krebs
KR102123365B1 (ko) 2015-07-28 2020-06-16 바이옴 테라퓨틱스 리미티드 항박테리아 치료제 및 예방제
US11305106B2 (en) * 2018-10-09 2022-04-19 Battelle Memorial Institute Mixed ionic electronic conductors: devices, systems and methods of use
DE102024003705A1 (de) 2024-11-12 2026-05-13 Alienworks S.A. Transdermales Pflaster zur gesteuerten Abgabe von Wirkstoffen unter Verwendung einer elektronischen Regelautomatik in Form einer Smartwatch

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
AT371342B (de) * 1978-10-12 1983-06-27 Tapper Robert Elektrodenanordnung zur lokalen einleitung von gleichstrom in die haut eines lebenden koerpers, insbesondere zur iontophoretischen behandlung
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4486194A (en) * 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4585652A (en) * 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US5042975A (en) * 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4931046A (en) * 1987-05-15 1990-06-05 Newman Martin H Iontophoresis drug delivery system
US4942883A (en) * 1987-09-29 1990-07-24 Newman Martin H Drug delivery device
IL86076A (en) * 1988-04-14 1992-12-01 Inventor S Funding Corp Ltd Transdermal drug delivery device
AU628419B2 (en) * 1988-10-26 1992-09-17 Hisamitsu Pharmaceutical Co. Ltd. Interface for electric endermism
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals

Also Published As

Publication number Publication date
EP0532451A1 (de) 1993-03-17
DE69207688D1 (de) 1996-02-29
DE69207688T2 (de) 1996-05-30
DK0532451T3 (da) 1996-03-18
ES2082423T3 (es) 1996-03-16
GR3019575T3 (en) 1996-07-31
EP0532451B1 (de) 1996-01-17
JPH05212124A (ja) 1993-08-24
US5356632A (en) 1994-10-18

Similar Documents

Publication Publication Date Title
DE69207688D1 (de) Einrichtung zur transdermalen Wirkstoffabgabe
AU591997B2 (en) Transdermal drug delivery device
CA2074467A1 (en) Skin electrode construction and transdermal drug delivery device utilizing same
ATE155681T1 (de) Einrichtung zur transmucosalen wirkstoffabgabe
DE59505328D1 (de) Transdermales system
DK0641561T3 (da) Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik
ATE225647T1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
DE69031083D1 (de) Gerät zur iontophoretischen verabreichung von medikamenten
EP0748636A3 (de) Schnittstelle für Iontophorese
BE905933A (fr) Emplatres transdermiques et dermiques comportant plusieurs subdivisions.
IL125088A0 (en) Modulation of TH1/TH2 cytokine expression
EP0480909A3 (en) Porous active carbon prepared from aromatic condensation polymer and use thereof in electrodes for electrochemical cells
DE69020173D1 (de) Aktives Matrix-Substrat und Anzeigevorrichtung mit dieser aktiven Matrix.
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
DE59106965D1 (de) Galvanisch aktives transdermales therapeutisches System.
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
AU1612588A (en) Pulsating transdermal drug delivery system
JPS5387251A (en) Display device
DE68916706D1 (de) Anzeigevorrichtung.
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)
ATE252406T1 (de) Elektrode für iontophorese
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
TW332920B (en) Display device
GB9827034D0 (en) Delivery formulation
EP1240899A3 (de) Regulierung der TH1/TH2 Cytokinexpression durch Ribavirin and Ribavirinanaloge in activierten T-Lymphocyten, zur Behandlung der HCV-Infektionen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee